Prophylactic use of inhalation steroid for radiation pneumonitis in patients with subclinical interstitial lung disease: prospective clinical study

Prophylactic use of inhalation steroid for radiation pneumonitis in patients with subclinical interstitial lung disease: prospective clinical study - Prophylactic use of inhalation steroid for radiation pneumonitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029721

Enrollment

Registered

2017-10-26

Start date

2014-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic malignant disease combined with subclinical interstitial lung disease

Interventions

Prophylactic use of inhalation steroid (ciclesonide, daily) during 8 months.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Histological diagnosis of thoracic cancer Interstitial lung disease on CT imaging without symptom and treatment history

Exclusion criteria

Exclusion criteria: Severe heat disease Active pulmonary disease

Design outcomes

Primary

Measure	Time frame
Occurrence rate of radiation pneumonia Breathing capacity CT imaging	—

Countries

Japan

Contacts

Public ContactTakayuki Ohguri

University of Occupational and Environmental Health Department of Radiology

ogurieye@med.uoeh-u.ac.jp093-691-7264

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026